Cytek Biosciences introduces a new high-dimensional sorter
Cytek Aurora CS harnesses power of innovative full-spectrum profiling technology; delivers seamless sorting experience
Cytek Aurora CS harnesses power of innovative full-spectrum profiling technology; delivers seamless sorting experience
First in Sphere Fluidics’ new range of 3D cell culture kits in partnership with ClexBio
The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)
From its expedited development to its far-reaching adoption, COVID-19 antigen testing is helping students and workforces safely return to daily life
Explore topics from optical spectroscopy, x-ray diffraction, high-resolution ion mobility mass spectrometry, CAR-T cell sensitivity and persistence
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines
Compared to traditional development approaches, mechanistic modelling saves significant time and materials on process development
Access to mechanical circulatory support devices is critical for advanced heart failure patients and can improve survival, clinical outcomes and quality of life
The catheter transforms care delivery by enabling access to structural heart procedures for patients with tricuspid regurgitation and other pathologies
Explore cutting-edge technologies and the latest resources to support your materials characterization
Check out this selection of resources designed to make it easier for your lab to hit its sustainability goals
The Epsilon 1 is the first analytical solution for this purpose without the need for helium
Explore expert webinars, free downloads, latest methods, and much more to help support biopharmaceutical research
Dr. Marco Caffio reveals how his team took on a seemingly impossible mission – to produce pristine, scalable, and reproducible graphene at a low cost